Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

Background: Chimeric antigen receptor (CAR)-modified T cells have successfully harnessed T cell immunity against malignancies, but they are by no means the only cell therapies in development for cancer. Main Text Summary: Systemic immunity is thought to play a key role in combatting neoplastic disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Shabnum, Burga, Rachel A., Powell, Allison B., Chorvinsky, Elizabeth A., Hoq, Nia, McCormack, Sarah E., Van Pelt, Stacey N., Hanley, Patrick J., Cruz, Conrad Russell Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467966/
https://www.ncbi.nlm.nih.gov/pubmed/31024832
http://dx.doi.org/10.3389/fonc.2019.00196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467966/
https://www.ncbi.nlm.nih.gov/pubmed/31024832
http://dx.doi.org/10.3389/fonc.2019.00196

Ejemplares similares